Blueprint to Close the Women%E2%80%99s Health Gap 2025

Contents Introduction 1 Selection of high-impact conditions selected for year 1, countries and metrics 1.1 Selected conditions 1.2 Selection of countries 1.3 Selection of metrics 2 Programme-level metrics 2.1 Data-gap metrics 2.1.1 Metric 1: Medication volume tracking 2.2 Care delivery gap metrics 2.2.1 Metric 2: Clinical practice guidelines 2.2.2 Metric 3: Mortality rate 2.3 Efficacy gap metrics 2.3.1 Metric 4: Research funds 2.3.2 Metric 5: Assets in the pipeline 2.3.3 Metric 6: Number of clinical trials 2.3.4 Metric 7: Sex-disaggregated data 3 Condition-level metrics 3.1 Metric 1: Undercounting of prevalence 3.2 Metric 2: Number of patient registries 3.3 Metric 3: Number of centres of excellence – endometriosis 3.4 Metric 4: Number of countries with published workplace guidance 3.5 Metric 5: Skilled birth attendants 3.6 Metric 6: Number of countries including HPV in their national vaccination programmes 3.7 Metric 7: Percentage coverage of the HPV vaccination programmes 3.8 Metric 8: Number of countries using the HPV test in screening programmes 3.9 Metric 9: Number of countries with screening programmes in line with the WHO 3.10 Metric 10: Percentage participation in screening programmes36 36 36 37 37 39 39 39 40 40 40 41 41 42 42 43 43 43 44 44 44 45 45 45 46 46 46 Blueprint to Close the Women’s Health Gap: How to Improve Lives and Economies for All 35